BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
Federal Trade Commission
Chinese Patent Office
Covington
Fish and Richardson
Johnson and Johnson
Chubb
QuintilesIMS
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

DEMADEX Drug Profile

« Back to Dashboard

When do Demadex patents expire, and what generic alternatives are available?

Demadex is a drug marketed by Roche and Mylan Speciality Lp and is included in two NDAs.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

US Patents and Regulatory Information for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-001 Aug 23, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Merck
Colorcon
QuintilesIMS
Teva
Chubb
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot